MTP gene polymorphisms and postprandial lipemia in familial combined hyperlipidemia: Effects of treatment with atorvastatin

Castro Cabezas, 1993, Impaired chylomicron remnant clearance in familial combined hyperlipidemia, Arterioscler Thromb, 13, 804, 10.1161/01.ATV.13.6.804 Hegele, 2009, A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia, Hum Mol Genet, 18, 4189, 10.1093/hmg/ddp361 Aouizerat, 1999, Novel genes for familial combined hyperlipidemia, Curr Opin Lipidol, 10, 113, 10.1097/00041433-199904000-00005 Eichenbaum-Voline, 2004, Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia, Arterioscler Thromb Vasc Biol, 24, 167, 10.1161/01.ATV.0000099881.83261.D4 Plaisier, 2009, A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia, PLoS Genet, 5, e1000642, 10.1371/journal.pgen.1000642 Huertas-Vazquez, 2010, A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia, Hum Genet, 127, 83, 10.1007/s00439-009-0749-z Teslovich, 2010, Biological, clinical and population relevance of 95 loci for blood lipids, Nature, 466, 707, 10.1038/nature09270 Sabatti, 2009, Genome-wide association analysis of metabolic traits in a birth cohort from a founder population, Nat Genet, 41, 35, 10.1038/ng.271 Saxena, 2007, Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels, Science, 316, 1331, 10.1126/science.1142358 Wallace, 2008, Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia, Am J Hum Genet, 82, 139, 10.1016/j.ajhg.2007.11.001 Willer, 2008, Newly identified loci that influence lipid concentrations and risk of coronary artery disease, Nat Genet, 40, 161, 10.1038/ng.76 Narcisi, 1995, Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia, Am J Hum Genet, 57, 1298 Ohashi, 2000, Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia, J.Lipid Res, 41, 1199, 10.1016/S0022-2275(20)33426-X Wetterau, 1992, Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia, Science, 258, 999, 10.1126/science.1439810 Karpe, 1998, A common functional polymorphism in the promoter region of the microsomal triglyceride transfer protein gene influences plasma LDL levels, Arterioscler Thromb Vasc Biol, 18, 756, 10.1161/01.ATV.18.5.756 Lundahl, 2000, A functional polymorphism in the promoter region of the microsomal triglyceride transfer protein (MTP−493G/T) influences lipoprotein phenotype in familial hypercholesterolemia, Arterioscler Thromb Vasc Biol, 20, 1784, 10.1161/01.ATV.20.7.1784 Lundahl, 2006, Microsomal triglyceride transfer protein−493T variant reduces IDL plus LDL apoB production and the plasma concentration of large LDL particles, Am J Physiol Endocrinol Metab, 290, E739, 10.1152/ajpendo.00376.2005 Lundahl, 2002, Postprandial plasma ApoB-48 levels are influenced by a polymorphism in the promoter of the microsomal triglyceride transfer protein gene, Arterioscler Thromb Vasc Biol, 22, 289, 10.1161/hq0202.102876 Ledmyr, 2002, Variants of the microsomal triglyceride transfer protein gene are associated with plasma cholesterol levels and body mass index, J Lipid Res, 43, 51, 10.1016/S0022-2275(20)30186-3 Phillips, 2004, Microsomal triglyceride transfer protein polymorphisms and lipoprotein levels in type 2 diabetes, QJM, 97, 211, 10.1093/qjmed/hch040 Garcia-Garcia, 2005, Influence of microsomal triglyceride transfer protein promoter polymorphism−493GT on fasting plasma triglyceride values and interaction with treatment response to atorvastatin in subjects with heterozygous familial hypercholesterolaemia, Pharmacogenet Genomics, 15, 211, 10.1097/01213011-200504000-00004 Gastaldi, 2007, Sex-specific association of fatty acid binding protein 2 and microsomal triacylglycerol transfer protein variants with response to dietary lipid changes in the 3-mo Medi-RIVAGE primary intervention study, Am J Clin Nutr, 86, 1633, 10.1093/ajcn/86.6.1633 Zak, 2008, The influence of polymorphism of −493G/T MTP gene promoter and metabolic syndrome on lipids, fatty acids and oxidative stress, J Nutr Biochem, 19, 634, 10.1016/j.jnutbio.2007.09.001 Aouizerat, 1999, Linkage of a candidate gene locus to familial combined hyperlipidemia: lecithin:cholesterol acyltransferase on 16q, Arterioscler Thromb Vasc Biol, 19, 2730, 10.1161/01.ATV.19.11.2730 Verseyden, 2002, Postprandial changes of apoB-100 and apoB-48 in TG rich lipoproteins in familial combined hyperlipidemia, J Lipid Res, 43, 274, 10.1016/S0022-2275(20)30169-3 Dallinga-Thie, 1995, Apolipoprotein E2/E3/E4 genotyping with agarose gels, Clin Chem, 41, 73, 10.1093/clinchem/41.1.73 Burstein, 1970, Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions, J Lipid Res, 11, 583, 10.1016/S0022-2275(20)42943-8 Verseyden, 2004, Effects of atorvastatin on fasting plasma and marginated apolipoproteins B48 and B100 in large, triglyceride-rich lipoproteins in familial combined hyperlipidemia, J Clin Endocrinol Metab, 89, 5021, 10.1210/jc.2003-032171 Karpe, 1994, Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE, J Lipid Res, 35, 1311, 10.1016/S0022-2275(20)39974-0 Brunzell, 1983, Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia, J Lipid Res, 24, 147, 10.1016/S0022-2275(20)38008-1 Duez, 2008, Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans, Circulation, 117, 2369, 10.1161/CIRCULATIONAHA.107.739888 Hsieh, 2008, Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivity, Atheroscler Suppl, 9, 7, 10.1016/j.atherosclerosissup.2008.05.011 Lewis, 1991, Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities, J Clin Endocrinol Metab, 72, 934, 10.1210/jcem-72-4-934 Phillips, 2006, Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition, Atherosclerosis, 187, 57, 10.1016/j.atherosclerosis.2005.08.020 Sato, 1999, Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription, J Biol Chem, 274, 24714, 10.1074/jbc.274.35.24714